VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
INSP
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
INSPInspire Medical Systems, Inc.
$44.93$1.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksINSPQuarterly Financials

Inspire Medical Systems, Inc. (INSP) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Inspire Medical Systems, Inc. (INSP) quarterly income statement — complete revenue, gross profit & net income history

INSP Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue204.58M269.08M224.5M217.09M201.32M239.72M203.19M195.88M164.01M192.51M153.3M151.09M127.9M137.9M109.19M91.39M69.38M78.4M61.69M52.96M
Revenue Growth %1.62%12.25%10.49%10.82%22.75%24.52%32.54%29.65%28.24%39.6%40.4%65.33%84.34%75.9%77.01%72.56%71.94%70.4%72.1%334.7%
Cost of Goods Sold27.67M36.07M31.77M34.67M30.71M35.99M32.4M29.84M24.76M28.05M24.38M24.25M19.89M22.15M19.79M14.17M10M11.16M8.62M7.52M
COGS % of Revenue13.53%13.41%14.15%15.97%15.25%15.01%15.94%15.24%15.09%14.57%15.9%16.05%15.55%16.06%18.12%15.51%14.42%14.23%13.98%14.2%
Gross Profit176.91M233.01M192.73M182.41M170.61M203.73M170.79M166.04M139.25M164.45M128.92M126.84M108.01M115.75M89.4M77.21M59.38M67.24M53.06M45.44M
Gross Margin %86.47%86.59%85.85%84.03%84.75%84.99%84.06%84.77%84.91%85.43%84.1%83.95%84.45%83.94%81.88%84.49%85.58%85.77%86.02%85.8%
Gross Profit Growth %3.69%14.37%12.84%9.86%22.52%23.88%32.48%30.91%28.93%42.08%44.2%64.27%81.9%72.14%68.49%69.92%72.76%73.09%73.23%344.24%
Operating Expenses178.03M186.9M183.08M185.73M172.09M171.85M156.47M160.94M154.47M155.16M142.39M143.44M127.51M116.08M106.6M91.22M75.43M69.06M62.86M57.98M
OpEx % of Revenue87.02%69.46%81.55%85.56%85.48%71.69%77.01%82.16%94.18%80.6%92.88%94.93%99.7%84.18%97.63%99.82%108.72%88.09%101.9%109.49%
Selling, General & Admin152.2M161.95M158.87M159.52M144.29M141.51M130.39M132.08M125.62M124.11M113.25M112.62M101.99M94.83M85.6M76.69M63.56M58.77M53.24M48.7M
SG&A % of Revenue74.4%60.19%70.77%73.48%71.67%59.03%64.17%67.43%76.59%64.47%73.87%74.54%79.74%68.77%78.4%83.91%91.61%74.96%86.31%91.95%
Research & Development25.83M24.94M24.21M26.21M27.8M30.34M26.08M28.86M28.85M31.05M29.14M30.82M25.52M21.25M20.99M14.53M11.87M10.29M9.61M9.29M
R&D % of Revenue12.62%9.27%10.78%12.07%13.81%12.65%12.84%14.73%17.59%16.13%19.01%20.4%19.95%15.41%19.23%15.9%17.11%13.13%15.59%17.54%
Other Operating Expenses00000000000000000000
Operating Income-1.12M46.11M9.64M-3.32M-1.49M31.88M14.32M5.1M-15.22M9.3M-13.47M-16.6M-19.5M-335K-17.19M-14.01M-16.06M-1.82M-9.8M-12.54M
Operating Margin %-0.55%17.14%4.3%-1.53%-0.74%13.3%7.05%2.6%-9.28%4.83%-8.79%-10.99%-15.25%-0.24%-15.75%-15.33%-23.14%-2.32%-15.88%-23.69%
Operating Income Growth %24.71%44.62%-32.64%-165.03%90.24%242.95%206.29%130.72%21.95%2875.22%21.65%-18.5%-21.44%81.6%-75.52%-11.66%-2.34%74.21%0.97%45.02%
EBITDA-1.12M49.93M13.32M98K1.56M34.36M16.17M6.48M-14.38M10.11M-12.69M-15.94M-18.91M234K-16.68M-13.59M-15.7M-1.48M-9.46M-12.24M
EBITDA Margin %-0.55%18.56%5.93%0.05%0.77%14.33%7.96%3.31%-8.77%5.25%-8.28%-10.55%-14.78%0.17%-15.28%-14.87%-22.62%-1.88%-15.34%-23.11%
EBITDA Growth %-171.71%45.31%-17.61%-98.49%110.84%239.75%227.37%140.66%23.94%4222.22%23.9%-17.29%-20.44%115.84%-76.33%-11.03%-1.57%78.31%2.27%45.9%
D&A (Non-Cash Add-back)03.82M3.68M3.41M3.04M2.48M1.85M1.38M839K817K777K659K593K569K513K417K359K344K336K304K
EBIT046.11M13.56M-2.33M-1.49M54.28M20.33M10.85M-15.22M15.24M-13.47M-16.6M-19.5M3.27M-15.95M-13.85M-16.07M-1.83M-9.81M-12.53M
Net Interest Income03.88M3.97M4.48M5.07M5.53M5.89M5.88M5.92M5.87M5.5M4.92M4.27M3.37M694K-197K-493K-523K-515K-499K
Interest Income04M3.98M4.49M5.07M5.55M5.89M5.88M5.92M5.87M5.5M4.92M4.27M3.37M1.35M297K34K15K22K31K
Interest Expense0122K11K4K022K00000000656K494K527K538K537K530K
Other Income/Expense3.52M4.21M3.91M984K5.64M4.75M6.01M5.75M5.86M5.94M5.27M4.86M4.29M3.61M593K-341K-538K-550K-548K-518K
Pretax Income2.4M50.32M13.55M-2.33M4.16M36.64M20.33M10.85M-9.36M15.24M-8.2M-11.74M-15.21M3.27M-16.6M-14.35M-16.59M-2.37M-10.34M-13.06M
Pretax Margin %1.17%18.7%6.04%-1.07%2.07%15.28%10%5.54%-5.7%7.92%-5.35%-7.77%-11.89%2.37%-15.2%-15.7%-23.92%-3.02%-16.77%-24.66%
Income Tax13.69M-85.77M3.62M1.26M1.17M1.41M1.83M1.05M650K477K340K214K216K125K246K142K100K20K3K26K
Effective Tax Rate %571.17%-170.45%26.71%-54.03%28.06%3.85%9%9.71%-6.95%3.13%-4.15%-1.82%-1.42%3.82%-1.48%-0.99%-0.6%-0.84%-0.03%-0.2%
Net Income-11.29M136.09M9.93M-3.59M2.99M35.22M18.5M9.79M-10.01M14.76M-8.54M-11.95M-15.42M3.15M-16.85M-14.49M-16.69M-2.39M-10.35M-13.09M
Net Margin %-5.52%50.58%4.42%-1.65%1.49%14.69%9.1%5%-6.1%7.67%-5.57%-7.91%-12.06%2.28%-15.43%-15.86%-24.06%-3.05%-16.77%-24.71%
Net Income Growth %-477.47%286.36%-46.3%-136.68%129.91%138.6%316.59%181.94%35.13%368.67%49.31%17.52%7.61%231.74%-62.82%-10.71%-2.95%68.05%0.37%43.31%
Net Income (Continuing)-11.29M136.09M9.93M-3.59M2.99M35.22M18.5M9.79M-10.01M14.76M-8.54M-11.95M-15.42M3.15M-16.85M-14.49M-16.69M-2.39M-10.35M-13.09M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.394.660.34-0.120.101.150.600.32-0.340.49-0.29-0.41-0.530.10-0.60-0.53-0.61-0.09-0.38-0.48
EPS Growth %-495.14%305.22%-43.33%-137.5%129.03%134.69%306.9%178.05%35.85%390%51.67%22.64%13.11%211.11%-57.89%-10.42%-1.67%67.86%2.56%45.45%
EPS (Basic)-0.394.700.34-0.120.101.180.620.33-0.340.50-0.29-0.41-0.530.11-0.60-0.53-0.61-0.09-0.38-0.48
Diluted Shares Outstanding28.7M29.22M29.6M29.51M30.31M30.75M30.63M30.41M29.62M30.24M29.37M29.23M29.09M30.21M28.23M27.59M27.52M27.37M27.3M27.23M
Basic Shares Outstanding28.7M28.94M29.33M29.51M29.7M29.83M29.88M29.73M29.62M29.52M29.37M29.23M29.09M28.93M28.23M27.59M27.52M27.37M27.3M27.23M
Dividend Payout Ratio--------------------